TGFB1 and pancreatic neoplasm: Similarly, in breast and pancreatic cancer cell lines, TGF-β signaling via EMT was shown to support cisplatin resistance by increasing the expression of deubiquitinase USP27X, which, in turn, increases the stability of the EMT-associated protein SNAIL1 [125].